EIPM: Combination Therapy Boosts Response, Cuts Treatment Time
Combination Therapy Boosts Lung Cancer Patients’ Response, Cuts Treatment Time in Phase 2 Trial Combining immunotherapy with targeted radiation resulted in a greater response rate than immunotherapy alone in a phase 2 clinical trial in...
Read more